Pfizer suit against sites selling drug advertized as Ranbaxy's

Wednesday, 05 May 2004, 19:30 IST
Printer Print Email Email
NEW YORK: Pfizer Inc. said Tuesday it has filed lawsuits against five online drug stores for allegedly selling an unapproved version of its cholesterol-controlling drug, advertised as being manufactured by Ranbaxy. The suits were filed in US district courts in Delaware and Connecticut against Generic Lipitors, Online Rx DrugStore, WorldMedsRX, B. M. International, and Offshore Pharma, Pfizer said in a statement. These firms run websites, whose addresses have been stated respectively as genericlipitors.com, onlinerxdrugstore.com, worlmedsrx.com, www.b-m-international.com, and offshorepharma.com. Pfizer said the sites market a product called 'Storvas' and added that they are advertised as being manufactured by Ranbaxy Pharmaceuticals Inc. of India. The lawsuits seek injunctions against further sales of 'Storvas' and claim damages for infringement of Pfizer's patent and trademark rights for Lipitor, the statement said. The complaints also seek to remove references to Lipitor in advertising materials and to eliminate computer links that misdirect patients to an illegal, unapproved product.
Source: IANS
siliconindia